187 related articles for article (PubMed ID: 16525356)
1. Inhibition of poly(adp-ribose) polymerase reduces cardiomyocytic apoptosis after global cardiac arrest under cardiopulmonary bypass.
Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Jing Lin P
Shock; 2006 Feb; 25(2):168-75. PubMed ID: 16525356
[TBL] [Abstract][Full Text] [Related]
2. Cardiomyocytic apoptosis following global cardiac ischemia and reperfusion can be attenuated by peroxisome proliferator-activated receptor alpha but not gamma activators.
Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
Shock; 2006 Sep; 26(3):262-70. PubMed ID: 16912651
[TBL] [Abstract][Full Text] [Related]
3. Cardioplegia-induced cardiac arrest under cardiopulmonary bypass decreased nitric oxide production which induced cardiomyocytic apoptosis via nuclear factor kappa B activation.
Yeh CH; Chen TP; Lee CH; Wu YC; Lin YM; Lin PJ
Shock; 2007 Apr; 27(4):422-8. PubMed ID: 17414426
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of NFkappaB activation with curcumin attenuates plasma inflammatory cytokines surge and cardiomyocytic apoptosis following cardiac ischemia/reperfusion.
Yeh CH; Chen TP; Wu YC; Lin YM; Jing Lin P
J Surg Res; 2005 May; 125(1):109-16. PubMed ID: 15836859
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide attenuates cardiomyocytic apoptosis via diminished mitochondrial complex I up-regulation from cardiac ischemia-reperfusion injury under cardiopulmonary bypass.
Yeh CH; Lin YM; Wu YC; Wang YC; Lin PJ
J Thorac Cardiovasc Surg; 2004 Aug; 128(2):180-8. PubMed ID: 15282453
[TBL] [Abstract][Full Text] [Related]
6. HO-1 activation can attenuate cardiomyocytic apoptosis via inhibition of NF-kappaB and AP-1 translocation following cardiac global ischemia and reperfusion.
Yeh CH; Chen TP; Wang YC; Lin YM; Lin PJ
J Surg Res; 2009 Jul; 155(1):147-56. PubMed ID: 19181338
[TBL] [Abstract][Full Text] [Related]
7. Prevention of myocardial reperfusion injury by poly(ADP-ribose) synthetase inhibitor, 3-aminobenzamide, in cardioplegic solution: in vitro study of isolated rat heart model.
Yamazaki K; Miwa S; Ueda K; Tanaka S; Toyokuni S; Unimonh O; Nishimura K; Komeda M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):270-5. PubMed ID: 15296882
[TBL] [Abstract][Full Text] [Related]
8. Continuous tepid blood cardioplegia can preserve coronary endothelium and ameliorate the occurrence of cardiomyocyte apoptosis.
Yeh CH; Wang YC; Wu YC; Chu JJ; Lin PJ
Chest; 2003 May; 123(5):1647-54. PubMed ID: 12740286
[TBL] [Abstract][Full Text] [Related]
9. Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes.
Fischer UM; Klass O; Stock U; Easo J; Geissler HJ; Fischer JH; Bloch W; Mehlhorn U
Eur J Cardiothorac Surg; 2003 Jun; 23(6):984-90. PubMed ID: 12829076
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocytic apoptosis limited by bradykinin via restoration of nitric oxide after cardioplegic arrest.
Yeh CH; Chen TP; Wang YC; Lin YM; Fang SW
J Surg Res; 2010 Sep; 163(1):e1-9. PubMed ID: 20638673
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model.
Yamazaki K; Tanaka S; Sakata R; Miwa S; Oriyanhan W; Takaba K; Minakata K; Marui A; Ikeda T; Toyokuni S; Komeda M; Ueda K
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):143-7. PubMed ID: 22168830
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase inhibition improves postischemic myocardial function after cardioplegia-cardiopulmonary bypass.
Khan TA; Ruel M; Bianchi C; Voisine P; Komjáti K; Szabo C; Sellke FW
J Am Coll Surg; 2003 Aug; 197(2):270-7. PubMed ID: 12892811
[TBL] [Abstract][Full Text] [Related]
13. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system.
Halmosi R; Berente Z; Osz E; Toth K; Literati-Nagy P; Sumegi B
Mol Pharmacol; 2001 Jun; 59(6):1497-505. PubMed ID: 11353811
[TBL] [Abstract][Full Text] [Related]
14. INO-1001 a novel poly(ADP-ribose) polymerase (PARP) inhibitor improves cardiac and pulmonary function after crystalloid cardioplegia and extracorporal circulation.
Szabó G; Soós P; Mandera S; Heger U; Flechtenmacher C; Bährle S; Seres L; Cziráki A; Gries A; Zsengellér Z; Vahl CF; Hagl S; Szabó C
Shock; 2004 May; 21(5):426-32. PubMed ID: 15087818
[TBL] [Abstract][Full Text] [Related]
15. Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation.
Zhang Y; Zhang X; Park TS; Gidday JM
J Cereb Blood Flow Metab; 2005 Jul; 25(7):868-77. PubMed ID: 15729291
[TBL] [Abstract][Full Text] [Related]
16. Increased poly(ADP-ribosyl)ation in peripheral leukocytes and the reperfused myocardium tissue of rats with ischemia/reperfusion injury: prevention by 3-aminobenzamide treatment.
Zhang LQ; Qi GX; Jiang DM; Tian W; Zou JL
Shock; 2012 May; 37(5):492-500. PubMed ID: 22266967
[TBL] [Abstract][Full Text] [Related]
17. Minocycline protects cardiac myocytes against simulated ischemia–reperfusion injury by inhibiting poly(ADP-ribose) polymerase-1.
Tao R; Kim SH; Honbo N; Karliner JS; Alano CC
J Cardiovasc Pharmacol; 2010 Dec; 56(6):659-68. PubMed ID: 20881608
[TBL] [Abstract][Full Text] [Related]
18. Indices of apoptosis activation after blood cardioplegia and cardiopulmonary bypass.
Ramlawi B; Feng J; Mieno S; Szabo C; Zsengeller Z; Clements R; Sodha N; Boodhwani M; Bianchi C; Sellke FW
Circulation; 2006 Jul; 114(1 Suppl):I257-63. PubMed ID: 16820582
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress.
Bowes J; McDonald MC; Piper J; Thiemermann C
Cardiovasc Res; 1999 Jan; 41(1):126-34. PubMed ID: 10325960
[TBL] [Abstract][Full Text] [Related]
20. Suppression of poly (ADP-ribose) polymerase activation by 3-aminobenzamide in a rat model of myocardial infarction: long-term morphological and functional consequences.
Liaudet L; Szabó E ; Timashpolsky L; Virág L; Cziráki A; Szabó C
Br J Pharmacol; 2001 Aug; 133(8):1424-30. PubMed ID: 11498530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
